FDA NDC Directory · JSON-LD · Markdown

deferasirox

NDC 68462-494 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Labeler / ManufacturerGlenmark Pharmaceuticals Inc., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA209433
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsDEFERASIROX (125 mg/1)
Marketing started20200106
Package count1

External sources

Source: openFDA. Public-domain (CC0).